Judy Maddox

5.8k citations
19 papers · 3.7k indexed · 3 hit papers · h-index 15

Judy Maddox

19 papers receiving 3.7k citations

Hit Papers

Romosozumab Treatment in Postmenopausal Women with Osteop...20142026201820222016201720142505007501000

Peers

Judy Maddox
Comparison fields: 5 of 92
  • Orthopedics and Sports Medicine 2.4k
  • Molecular Biology 2.0k
  • Oncology 1.9k
  • Surgery 503
  • Genetics 424
Replace Matt Austin with:
Matt Austin United States
J.J. Body Belgium
David W. Donley United States
Cassandra E. Milmont United States
D Ethgen Belgium
Anastasia G. Daifotis United States
Deborah Wenkert United States
D. Wattie New Zealand
Irene E. M. Bultink Netherlands
Martin Pecherstorfer Austria
Judy Maddox relative to Matt Austin United States Matt Austin's profile →
Citations per field
00.5×3.2×
Matt Austin · 1×
Citations per year

Countries citing papers authored by Judy Maddox

Since Specialization
Citations

This map shows the geographic impact of Judy Maddox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judy Maddox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judy Maddox more than expected).

Fields of papers citing papers by Judy Maddox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judy Maddox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judy Maddox. The network helps show where Judy Maddox may publish in the future.

Co-authorship network of co-authors of Judy Maddox

This figure shows the co-authorship network connecting the top 25 collaborators of Judy Maddox. A scholar is included among the top collaborators of Judy Maddox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judy Maddox. Judy Maddox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 14
2 14
3 21
4 35
5 60
6 36
7 75
8 159
9 201
10 75
11
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosisbreakdown →
942
12
Romosozumab Treatment in Postmenopausal Women with Osteoporosisbreakdown →
1131
13 6
14 21
15
Romosozumab in Postmenopausal Women with Low Bone Mineral Densitybreakdown →
886
16 5
17
Clinical trial safety and mortality analyses in patients receiving etanercept across approved indications.
37
18 20
19 1

About Judy Maddox

Judy Maddox is a scholar working on Orthopedics and Sports Medicine, Oncology and Gastroenterology, having authored 19 papers that have together received 3.7k indexed citations. Recurring topics across this work include Bone health and treatments (12 papers), Bone Metabolism and Diseases (11 papers) and Bone health and osteoporosis research (10 papers). The work is most often cited by research in Orthopedics and Sports Medicine (2.4k citations), Oncology (1.9k citations) and Nephrology (271 citations). Judy Maddox has collaborated with scholars based in United States, Belgium and Canada. Frequent co-authors include Andreas Grauer, Paul Meisner, Cesar Libanati, Michelle Fan, Akimitsu Miyauchi, Jeffrey Petersen, Andrew C. Karaplis, Thierry Thomas, Mattias Lorentzon and Kenneth G. Saag. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and The Journal of Clinical Endocrinology & Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026